Rho
AI-driven opportunistic screening system for low bone mineral density using routinely captured x-rays.
What it does
AI-driven opportunistic screening system for low bone mineral density using routinely captured x-rays. Licensed by Health Canada; FDA De Novo Marketing Authorization.
- AI-assisted bone age assessment
- opportunistic screening for osteoporosis risk
- improving population bone health
- reducing inter-rater variability in imaging assessments
- Category
- Diagnostics and imaging
- Built for
- Healthcare and life sciences
- Users
- Healthcare providers, Pediatric radiologists, Orthopedic surgeons
- Public API
- Not offered
Not yet disclosed: deployment options, platforms, languages and support channels.
Pricing
- Free trial$0
Prices as published by 16BIT, checked Oct 2026.
Security and compliance
As reported by 16BIT. Ask for audit reports before you buy.
- commercially acceptable means to protect personal data
Reviews
No reviews yet
Reviews come from people who use Rho at work. Share how your team uses it to help other buyers decide.
Alternatives
Precision Cardiac Amyloid
by InVision Medical Technology
AI screening for cardiac amyloidosis, a rare, underdiagnosed, and now-treatable disease, from routine transthoracic echocardiography.
Referral Portal
by AlemHealth
Seamless study sharing and incoming orders between referring physicians and imaging centers.
Biobeat Blood Pressure Monitor
by Instalab
An FDA-cleared, single-use monitor that tracks blood pressure continuously over 24 hours, giving a fuller picture than one-time traditional cuff readings.
Imaging
by Perceptive
Handheld intraoral scanner using advanced OCT technology to capture 3D volumetric data including below the gum line, through fluids, and under the tooth surface, without ionizin...
Scanbase Platform
by Scanbase, Inc.
Platform for converting photos of rapid diagnostic tests into positive or negative results, with a module-based pricing calculator covering selected diagnostic modules.
DovaVision BE
by Dova Health Intelligence
AI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma (EAC) detection.
Is this your product?
Claim it to keep details accurate and submit evidence for the next ranking review.
Claim Rho